Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis

Ocul Immunol Inflamm. 2022 Feb 17;30(2):457-462. doi: 10.1080/09273948.2020.1815799. Epub 2020 Sep 23.

Abstract

Purpose: To examine the diagnostic and prognostic roles of serum interleukin-6 levels in patients with uveitis.

Methods: This was a retrospective observational case series. Demographic and clinical characteristics were compared between Group One (sixty patients) with normal serum IL-6 levels and Group Two (twenty patients) with high serum interleukin-6 levels.

Results: Mean IL-6 level was 1.77 ± 0.97 pg/ml and 10.2 ± 9.7 pg/ml in Group One and Group Two respectively. Age, presence of systemic disease, and mean number of flare-ups were statistically significant (p = .015, p = .000, p = .03, respectively). Multivariate analysis was performed on variables that were statistically significant in univariate analysis and showed that three variables had significant correlation with IL-6 levels in both groups: systemic disease (OR = 10.83, p < .001), Age (OR = 0.95, p = .03) and number of flare-ups (OR = 2.9, p = .02).

Conclusion: Serum IL-6 levels can provide diagnostic and prognostic information in regard to the course of disease and its treatment.

Keywords: Behçet’s disease; interleukin-6; juvenile idiopathic arthritis; rheumatoid arthritis; systemic lupus erythematosus; uveitis.

Publication types

  • Observational Study

MeSH terms

  • Behcet Syndrome* / drug therapy
  • Humans
  • Interleukin-6 / blood*
  • Prognosis
  • Retrospective Studies
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy

Substances

  • IL6 protein, human
  • Interleukin-6